🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomised, placebo-controlled, dose-escalation study to investigate safe...
Status
Completed
Location
Richmond Pharmacology Ltd
Start Date
2012-11
Trial ID
NCT01713608
Treatments Being Tested
In this trial the safety, tolerability, pharmacokinetics and exploratory ph...
Status
Completed
Location
1313.2.44001 Boehringer Ingelheim Investigational Site
Start Date
2012-07
Trial ID
NCT01651598
Treatments Being Tested
JINZHEN is a botanical drug that contains eight chemical constituents extra...
Status
Completed
Location
Clearview Medical Research LLC
Start Date
2022-05-26
Trial ID
NCT05092503
Treatments Being Tested
HPV infection can lead to cancer, especially when precancerous lesions have...
Status
Unknown
Location
Hospital Ruber Internacional
Start Date
2023-06-07
Trial ID
NCT05916911
First evaluation of safety, tolerability, pharmacokinetics and the pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT02214914
Treatments Being Tested
To further test the effectiveness of oxytocin in heavy drinkers, half of th...
Status
Withdrawn
Location
Cort Pedersen
Start Date
2019-10
Trial ID
NCT03636555
The objective of the study is to evaluate the effects a complex recovery in...
Status
Completed
Location
ETH Zürich, Exercise Physiology Lab
Start Date
2020-09-10
Trial ID
NCT04508738
* Investigation of safety and tolerability of BI 653048 H3PO4 following the...
Status
Completed
Location
Multiple Locations
Start Date
2008-11
Trial ID
NCT02217644
A study to assess safety, pharmacokinetics and the effect of BIBT 986 BS, g...
Status
Completed
Location
Multiple Locations
Start Date
2001-08
Trial ID
NCT02182037
Treatments Being Tested
This study may discover that supplementing with probiotics LY-66, PL-02 can...
Status
Completed
Location
Glac Biotech Co., Ltd.
Start Date
2021-12-01
Trial ID
NCT06092723